Daniel Arias
Stock Analyst at Stifel
(4.31)
# 450
Out of 4,761 analysts
145
Total ratings
58.33%
Success rate
14.34%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Buy | $45 → $53 | $42.87 | +23.63% | 2 | Feb 21, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $10.90 | +65.14% | 6 | Feb 13, 2025 | |
| AVTR Avantor | Maintains: Buy | $28 → $26 | $17.30 | +50.29% | 8 | Feb 10, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $2.53 | +137.15% | 2 | Nov 13, 2024 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,550 → $1,450 | $1,286.54 | +12.71% | 7 | Nov 11, 2024 | |
| TEM Tempus AI | Downgrades: Hold | $45 → $65 | $68.09 | -4.54% | 2 | Nov 11, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $67 | $49.26 | +36.01% | 6 | Nov 6, 2024 | |
| WAT Waters | Maintains: Hold | $332 → $360 | $374.82 | -3.95% | 16 | Nov 4, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $680 → $665 | $532.55 | +24.87% | 15 | Oct 24, 2024 | |
| DHR Danaher | Maintains: Hold | $250 → $265 | $210.23 | +26.05% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $135.37 | +11.55% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $81 → $77 | $50.82 | +51.52% | 5 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $39.57 | +17.13% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $4.11 | +143.31% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $158.99 | +30.20% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $95 → $110 | $113.84 | -3.37% | 1 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $65 | $64.92 | +0.12% | 10 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $94.20 | +112.31% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $4.18 | +19.62% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $4.96 | +101.61% | 2 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.85 | +367.53% | 1 | Aug 24, 2021 |
Guardant Health
Feb 21, 2025
Maintains: Buy
Price Target: $45 → $53
Current: $42.87
Upside: +23.63%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $10.90
Upside: +65.14%
Avantor
Feb 10, 2025
Maintains: Buy
Price Target: $28 → $26
Current: $17.30
Upside: +50.29%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $2.53
Upside: +137.15%
Mettler-Toledo International
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,286.54
Upside: +12.71%
Tempus AI
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $68.09
Upside: -4.54%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $49.26
Upside: +36.01%
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $374.82
Upside: -3.95%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Buy
Price Target: $680 → $665
Current: $532.55
Upside: +24.87%
Danaher
Oct 23, 2024
Maintains: Hold
Price Target: $250 → $265
Current: $210.23
Upside: +26.05%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $135.37
Upside: +11.55%
May 20, 2024
Maintains: Hold
Price Target: $81 → $77
Current: $50.82
Upside: +51.52%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $39.57
Upside: +17.13%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $4.11
Upside: +143.31%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $158.99
Upside: +30.20%
Feb 2, 2024
Maintains: Hold
Price Target: $95 → $110
Current: $113.84
Upside: -3.37%
Feb 2, 2024
Downgrades: Hold
Price Target: $65
Current: $64.92
Upside: +0.12%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $94.20
Upside: +112.31%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $4.18
Upside: +19.62%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $4.96
Upside: +101.61%
Aug 24, 2021
Initiates: Buy
Price Target: $18
Current: $3.85
Upside: +367.53%